Trial: 202204039

A Phase 1/2 Study of VS-6766 in Combination with Sotorasib in Patients with KRAS G12C mutant Non-Small Cell Lung Cancer (NSCLC) (RAMP 203)

Phase

I/II

Principal Investigator

Govindan, Ramaswamy

Disease Site

Lung

Learn more about this study at: clinicaltrials.gov